Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Livia Lamartina1, Solange Grunenwald2, Malanie Roy3

  • 1Service de cancérologie endocrine, département d'Imagerie médicale, Gustave-Roussy, Villejuif, France.

Bulletin Du Cancer
|November 6, 2024
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pediatric robotic thyroid surgery and scar-related quality of life: A retrospective cohort of 40 patients.

Journal of pediatric surgery·2026
Same author

Prospective study on the [<sup>18</sup>F]FDOPA PET/CT role in the management of medullary thyroid cancer patients with high residual calcitonin level after surgery.

European journal of nuclear medicine and molecular imaging·2026
Same author

[<sup>177</sup>Lu]Lu-dota-tate versus sunitinib in patients with metastatic progressive neuroendocrine tumours of the pancreas (OCLURANDOM): a randomised, controlled, phase 2 trial.

The Lancet. Oncology·2026
Same author

Who leads, who treats, what dose? European paediatric differentiated thyroid carcinoma practice-an European Cooperative Study Group for Paediatric Rare Tumours survey.

European journal of endocrinology·2026
Same author

Impact of the French ENDOCAN-COMETE Network on Overall Survival in Rare Adrenocortical Carcinomas.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

Unraveling the Genetic Heterogeneity of Isolated Growth Hormone Deficiency: Insights from the GENHYPOPIT Cohort.

Hormone research in paediatrics·2026
Same journal

[ONCONNECTE À L'EMPLOI, feedback after three years of a program to prepare for returning to work after cancer in Franche-Comté].

Bulletin du cancer·2026
Same journal

[Off-label use of venetoclax in myeloma].

Bulletin du cancer·2026
Same journal

[Cemiplimab - Adjuvant treatment for the cutaneous squamous cell carcinomas with high risk of relapse, operated and treated by radiotherapy].

Bulletin du cancer·2026
Same journal

Real-world outcomes and management of endometrial cancer in France from 2016 to 2021 (MOONBEAM study).

Bulletin du cancer·2026
Same journal

[Cardiotoxicity in children and adolescents with acute leukemia: Recommendations from the Leukemia Committee of the French Society of Childhood Cancer (SFCE)].

Bulletin du cancer·2026
Same journal

[Reirradiation: A new therapeutic paradigm in oncology].

Bulletin du cancer·2026
See all related articles
This summary is machine-generated.

Thyroid cancer incidence is rising, prompting de-escalated management for low-risk papillary thyroid cancers. This review outlines best practices for localized follicular-derived thyroid cancer, including surgery, radioiodine, and follow-up.

Area of Science:

  • Endocrinology and Oncology
  • Thyroid Cancer Research
  • Clinical Practice Guidelines

Context:

  • Increasing global incidence of follicular-derived thyroid cancers, particularly low-recurrence-risk papillary thyroid cancers.
  • Implementation of de-escalated management strategies for initial treatment and follow-up.
  • Need for updated, consensus-based recommendations for localized disease.

Purpose:

  • To present best practice recommendations for managing localized follicular-derived thyroid cancer without distant metastases.
  • To consolidate guidelines from French, European, and international endocrinology, nuclear medicine, surgery, and oncology societies.
  • To address key aspects of treatment and follow-up, including surgical extent, radioiodine ablation, and surveillance.

Summary:

Keywords:
Cancer thyroïdien papillaireDeescalationDésescaladeIrathérapieLobectomieLobectomyPapillary thyroid cancerRadioiodineRisk stratificationRisque évolutifThyroïdectomieTotal thyroidectomy

Related Experiment Videos

  • Recommendations cover thyroid surgery extent and lymph node dissection for localized follicular-derived thyroid cancer.
  • Strategies for radioiodine ablation and follow-up protocols are detailed.
  • Specific guidance is provided for managing excellent prognosis papillary thyroid cancers measuring ≤ 10 mm.

    • Impact:

    • Facilitates standardized, evidence-based management of localized thyroid cancer.
    • Supports de-escalation of care for appropriate patient groups, optimizing resource utilization.
    • Aims to improve patient outcomes and reduce overtreatment in follicular-derived thyroid cancers.